Literature DB >> 32678339

Gene selection for the Australian Reproductive Genetic Carrier Screening Project ("Mackenzie's Mission").

Nigel G Laing1,2, Martin B Delatycki3,4, Edwin P Kirk5,6,7, Royston Ong1,2, Kirsten Boggs8,9,10, Tristan Hardy11,12,13, Sarah Righetti8,14, Ben Kamien15, Tony Roscioli8,16,17, David J Amor3,18, Madhura Bakshi19, Clara W T Chung14,19, Alison Colley19, Robyn V Jamieson10,20,21, Jan Liebelt22,23, Alan Ma10,24, Nicholas Pachter15,25, Sulekha Rajagopalan19, Anja Ravine26, Meredith Wilson10,24, Jade Caruana9,3, Rachael Casella27, Mark Davis26, Samantha Edwards1,2, Alison Archibald3,18,4, Julie McGaughran28,29, Ainsley J Newson30.   

Abstract

Reproductive genetic carrier screening aims to offer couples information about their chance of having children with certain autosomal recessive and X-linked genetic conditions. We developed a gene list for use in "Mackenzie's Mission", a research project in which 10,000 couples will undergo screening. Criteria for selecting genes were: the condition should be life-limiting or disabling, with childhood onset, such that couples would be likely to take steps to avoid having an affected child; and/or be one for which early diagnosis and intervention would substantially change outcome. Strong evidence for gene-phenotype relationship was required. Candidate genes were identified from OMIM and via review of 23 commercial and published gene lists. Genes were reviewed by 16 clinical geneticists using a standard operating procedure, in a process overseen by a multidisciplinary committee which included clinical geneticists, genetic counselors, an ethicist, a parent of a child with a genetic condition and scientists from diagnostic and research backgrounds. 1300 genes met criteria. Genes associated with non-syndromic deafness and non-syndromic differences of sex development were not included. Our experience has highlighted that gene selection for a carrier screening panel needs to be a dynamic process with ongoing review and refinement.

Entities:  

Mesh:

Year:  2020        PMID: 32678339      PMCID: PMC7852568          DOI: 10.1038/s41431-020-0685-x

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  21 in total

1.  Expanded carrier screening: too much of a good thing?

Authors:  Nancy C Rose
Journal:  Prenat Diagn       Date:  2015-08-14       Impact factor: 3.050

2.  Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome Resource.

Authors:  Natasha T Strande; Erin Rooney Riggs; Adam H Buchanan; Ozge Ceyhan-Birsoy; Marina DiStefano; Selina S Dwight; Jenny Goldstein; Rajarshi Ghosh; Bryce A Seifert; Tam P Sneddon; Matt W Wright; Laura V Milko; J Michael Cherry; Monica A Giovanni; Michael F Murray; Julianne M O'Daniel; Erin M Ramos; Avni B Santani; Alan F Scott; Sharon E Plon; Heidi L Rehm; Christa L Martin; Jonathan S Berg
Journal:  Am J Hum Genet       Date:  2017-05-25       Impact factor: 11.025

Review 3.  International perspectives on the implementation of reproductive carrier screening.

Authors:  Martin B Delatycki; Fowzan Alkuraya; Alison Archibald; Carlo Castellani; Martina Cornel; Wayne W Grody; Lidewij Henneman; Adonis S Ioannides; Edwin Kirk; Nigel Laing; Anneke Lucassen; John Massie; Juliette Schuurmans; Meow-Keong Thong; Irene van Langen; Joël Zlotogora
Journal:  Prenat Diagn       Date:  2019-11-29       Impact factor: 3.050

4.  Comprehensive mutation analysis of the CYP21A2 gene: an efficient multistep approach to the molecular diagnosis of congenital adrenal hyperplasia.

Authors:  Zhi Xu; Wuyan Chen; Deborah P Merke; Nazli B McDonnell
Journal:  J Mol Diagn       Date:  2013-09-23       Impact factor: 5.568

Review 5.  An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).

Authors:  B Wirth
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

6.  Technical standards and guidelines for spinal muscular atrophy testing.

Authors:  Thomas W Prior; Narasimhan Nagan; Elaine A Sugarman; Sat Dev Batish; Corey Braastad
Journal:  Genet Med       Date:  2011-07       Impact factor: 8.822

7.  The Israeli national population program of genetic carrier screening for reproductive purposes.

Authors:  Joël Zlotogora; Itamar Grotto; Ehud Kaliner; Ronni Gamzu
Journal:  Genet Med       Date:  2015-04-16       Impact factor: 8.822

8.  Responsible implementation of expanded carrier screening.

Authors:  Lidewij Henneman; Pascal Borry; Davit Chokoshvili; Martina C Cornel; Carla G van El; Francesca Forzano; Alison Hall; Heidi C Howard; Sandra Janssens; Hülya Kayserili; Phillis Lakeman; Anneke Lucassen; Sylvia A Metcalfe; Lovro Vidmar; Guido de Wert; Wybo J Dondorp; Borut Peterlin
Journal:  Eur J Hum Genet       Date:  2016-03-16       Impact factor: 4.246

9.  Feasibility of couple-based expanded carrier screening offered by general practitioners.

Authors:  Juliette Schuurmans; Erwin Birnie; Lieke M van den Heuvel; Mirjam Plantinga; Anneke Lucassen; Dorina M van der Kolk; Kristin M Abbott; Adelita V Ranchor; Agnes D Diemers; Irene M van Langen
Journal:  Eur J Hum Genet       Date:  2019-02-11       Impact factor: 4.246

10.  Expanded carrier screening for autosomal recessive conditions in health care: Arguments for a couple-based approach and examination of couples' views.

Authors:  Mirjam Plantinga; Erwin Birnie; Juliette Schuurmans; Anne H Buitenhuis; Elise Boersma; Anneke M Lucassen; Marian A Verkerk; Irene M van Langen; Adelita V Ranchor
Journal:  Prenat Diagn       Date:  2019-02-28       Impact factor: 3.050

View more
  13 in total

1.  Incidence of Duchenne muscular dystrophy in the modern era; an Australian study.

Authors:  Didu Kariyawasam; Arlene D'Silva; David Mowat; Jacqui Russell; Hugo Sampaio; Kristi Jones; Peter Taylor; Michelle Farrar
Journal:  Eur J Hum Genet       Date:  2022-06-27       Impact factor: 4.246

2.  Dynamics of reproductive genetic technologies: Perspectives of professional stakeholders.

Authors:  Ivy van Dijke; Carla G van El; Phillis Lakeman; Mariëtte Goddijn; Tessel Rigter; Martina C Cornel; Lidewij Henneman
Journal:  PLoS One       Date:  2022-06-21       Impact factor: 3.752

3.  2021 at European Journal of Human Genetics: the year in review.

Authors:  Alisdair McNeill
Journal:  Eur J Hum Genet       Date:  2022-01       Impact factor: 5.351

Review 4.  Ethical considerations in gene selection for reproductive carrier screening.

Authors:  Lisa Dive; Alison Dalton Archibald; Ainsley J Newson
Journal:  Hum Genet       Date:  2021-08-23       Impact factor: 5.881

5.  The landscape of autosomal-recessive pathogenic variants in European populations reveals phenotype-specific effects.

Authors:  Hila Fridman; Helger G Yntema; Reedik Mägi; Reidar Andreson; Andres Metspalu; Massimo Mezzavila; Chris Tyler-Smith; Yali Xue; Shai Carmi; Ephrat Levy-Lahad; Christian Gilissen; Han G Brunner
Journal:  Am J Hum Genet       Date:  2021-03-18       Impact factor: 11.043

6.  The ethics of preconception expanded carrier screening in patients seeking assisted reproduction.

Authors:  Guido de Wert; Sanne van der Hout; Mariëtte Goddijn; Rita Vassena; Lucy Frith; Nathalie Vermeulen; Ursula Eichenlaub-Ritter
Journal:  Hum Reprod Open       Date:  2021-02-12

7.  Evaluating the model of offering expanded genetic carrier screening to high school students within the Sydney Jewish community.

Authors:  Kristine Barlow-Stewart; Kayley Bardsley; Elle Elan; Jane Fleming; Yemima Berman; Ron Fleischer; Krista Recsei; Daniel Goldberg; John Tucker; Leslie Burnett
Journal:  J Community Genet       Date:  2021-11-30

8.  Qualitative study of GPs' views and experiences of population-based preconception expanded carrier screening in the Netherlands: bioethical perspectives.

Authors:  Sofia Morberg Jämterud; Anke Snoek; I M van Langen; Marian Verkerk; Kristin Zeiler
Journal:  BMJ Open       Date:  2021-12-09       Impact factor: 2.692

9.  Neonatal Bartter syndrome diagnosed by rapid genomics following low risk pre-conception carrier screening.

Authors:  Thomas A Forbes; Jane Wallace; Smitha Kumble; Martin B Delatycki; Zornitza Stark
Journal:  J Paediatr Child Health       Date:  2022-03-29       Impact factor: 1.929

10.  Attitudes toward population screening among people living with fragile X syndrome in the UK: 'I wouldn't wish him away, I'd just wish his fragile X syndrome away'.

Authors:  Felicity K Boardman
Journal:  J Genet Couns       Date:  2020-11-12       Impact factor: 2.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.